Cigna Group (NYSE:CI) Downgraded by Wall Street Zen to Hold

Key Points

• Wall Street Zen downgraded Cigna Group from “Buy” to “Hold,” although the broader analyst consensus remains “Moderate Buy,” with 15 Buy ratings and 8 Hold ratings and a consensus price target of $337.10.
• Cigna exceeded quarterly EPS expectations, reporting $7.78 versus the $7.60 consensus, while revenue rose 6.7% year over year to $70.04 billion; management issued fiscal 2026 EPS guidance of approximately $30.45.
• The stock opened at $280.51, near its 50-day and 200-day moving averages. Institutional investors own nearly 87% of shares, while insiders sold approximately $6.3 million worth of stock over the past three months.

Cigna Group (NYSE:CI - Get Free Report) was downgraded by research analysts at Wall Street Zen from a "buy" rating to a "hold" rating in a research report issued on Saturday, Wall Street Zen reports.

Other research analysts have also issued reports about the company. Morgan Stanley raised their price target on Cigna Group from $355.00 to $361.00 and gave the company an "overweight" rating in a report on Wednesday, May 20th. Mizuho increased their target price on shares of Cigna Group from $330.00 to $340.00 and gave the company an "outperform" rating in a research report on Monday, June 8th. Evercore assumed coverage on shares of Cigna Group in a research note on Wednesday. They set an "in-line" rating and a $290.00 target price on the stock. Wells Fargo & Company upped their price target on shares of Cigna Group from $305.00 to $307.00 and gave the stock an "equal weight" rating in a research note on Friday, July 31st. Finally, Weiss Ratings reiterated a "hold (c)" rating on shares of Cigna Group in a research note on Thursday, August 27th. Fifteen investment analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $337.10.

Cigna Group Stock Performance

CI opened at $280.51 on Friday. The business's 50 day moving average is $283.31 and its 200-day moving average is $280.78. The stock has a market cap of $74.12 billion, a PE ratio of 11.61, a price-to-earnings-growth ratio of 0.96 and a beta of 0.31. The company has a current ratio of 0.76, a quick ratio of 0.76 and a debt-to-equity ratio of 0.68. Cigna Group has a twelve month low of $239.51 and a twelve month high of $315.47.

Cigna Group (NYSE:CI - Get Free Report) last issued its quarterly earnings data on Thursday, July 30th. The health services provider reported $7.78 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $7.60 by $0.18. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%.The business had revenue of $70.04 billion during the quarter, compared to analyst estimates of $70.14 billion. During the same period in the prior year, the company posted $7.20 EPS. The business's revenue for the quarter was up 6.7% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.450- EPS. On average, analysts predict that Cigna Group will post 30.51 earnings per share for the current year.

Insider Transactions at Cigna Group

In other Cigna Group news, insider Nicole Jones sold 19,436 shares of the business's stock in a transaction dated Tuesday, August 4th. The stock was sold at an average price of $276.27, for a total transaction of $5,369,583.72. Following the sale, the insider owned 27,256 shares in the company, valued at approximately $7,530,015.12. The trade was a 41.63% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Everett Neville sold 617 shares of the company's stock in a transaction dated Thursday, September 3rd. The shares were sold at an average price of $284.05, for a total transaction of $175,258.85. Following the sale, the insider directly owned 5,053 shares of the company's stock, valued at $1,435,304.65. This represents a 10.88% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 22,730 shares of company stock worth $6,293,359 in the last three months. 0.60% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Cigna Group

Several hedge funds have recently made changes to their positions in CI. Sequoia Financial Advisors LLC boosted its stake in Cigna Group by 14.8% in the 2nd quarter. Sequoia Financial Advisors LLC now owns 12,092 shares of the health services provider's stock worth $3,333,000 after purchasing an additional 1,563 shares during the period. Tidal Investments LLC raised its stake in Cigna Group by 2.9% during the 2nd quarter. Tidal Investments LLC now owns 46,859 shares of the health services provider's stock valued at $12,918,000 after purchasing an additional 1,310 shares during the period. National Pension Service raised its stake in Cigna Group by 1.1% during the 2nd quarter. National Pension Service now owns 794,211 shares of the health services provider's stock valued at $218,948,000 after purchasing an additional 8,680 shares during the period. WINTON GROUP Ltd purchased a new stake in shares of Cigna Group in the second quarter valued at $1,312,000. Finally, Engineers Gate Manager LP boosted its position in shares of Cigna Group by 218.5% in the second quarter. Engineers Gate Manager LP now owns 26,087 shares of the health services provider's stock worth $7,192,000 after buying an additional 17,897 shares during the period. Hedge funds and other institutional investors own 86.99% of the company's stock.

About Cigna Group

The Cigna Group NYSE: CI is a global health services company that helps individuals, employers, health plans and government organizations access health care and related services. The company operates primarily through two businesses: Cigna Healthcare, which provides medical, behavioral health, dental and other health benefit products and services, and Evernorth Health Services, which offers pharmacy, care delivery and health benefits solutions.

Evernorth includes Express Scripts, a pharmacy benefit services provider that manages prescription drug benefits and operates home delivery and specialty pharmacy services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.